Depo-Medrol warning tops OSN’s news of the week
Here are some of the top stories on Healio.com/OSN in the past week:
Remove Depo-Medrol from ophthalmological surgical suites to avoid accidental retinal toxicity
Methylprednisolone acetate, which has similar packaging and appearance to triamcinolone acetonide, should be removed from shelves of ophthalmological surgical suites because intraocular use can lead to irreversible retinal necrosis and permanent vision loss. Read more.
FDA places clinical hold on IND application for Adverum’s wet AMD gene therapy
The FDA has placed a clinical hold on Adverum Biotechnologies’ investigational new drug application for its gene therapy candidate for wet age-related macular degeneration until it receives further information regarding the company’s manufacturing process. Read more.
Bees in the eye? Avoiding ocular injuries from dirt, debris and insects
A doctor at Fooyin Hospital in Taiwan recently described pulling four bees out of the eye of a patient who was complaining of extreme pain, swelling and tearing. Read more.
Partners named for children’s vision and eye health program
The Better Vision Together – Community of Practice program from the National Center for Children’s Vision and Eye Health at Prevent Blindness has its first partners. Read more.
Visual acuity gains reported in phase 3 trial of Leber hereditary optic neuropathy treatment
GenSight Biologics’ gene therapy treatment candidate for Leber hereditary optic neuropathy showed continuous recovery of visual function in a phase 3 trial. Read more.